M

Moleculin Biotech
D

MBRX

2.35000
USD
0.04
(1.73%)
مغلق
حجم التداول
1,120
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
7,236,188
أصول ذات صلة المقالات
المزيد

العنوان: Moleculin Biotech Inc

القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.